Porter G.A. Baxter N.N. Pisters P.W.

Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy.

Cancer Apr 1. 106: 1610-1616Gatta G. Capocaccia R. Botta L. et al.

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study.

Lancet Oncol. 18: 1022-1039

Soft tissue and bone tumours. WHO classification of tumours series; 5th edition, Vol. 3. International Agency for Research on Cancer (IARC); 2020.

Callegaro D. Raut C.P. Ng D. et al.

Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 years.

Ann Surg Oncol. 28: 1700-1709Tattersall H.L. Hodson J. Cardona K. et al.

Primary mesenteric sarcomas: Collaborative experience from the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).

J Surg Oncol. 123: 1057-1066

Liposarcoma: Multimodality Management and Future Targeted Therapies.

Surg Oncol Clin N Am. 25: 761-773Mandahl N. Akerman M. Aman P. et al.

Duplication of chromosome segment 12q15-24 is associated with atypical lipomatous tumors: a report of the CHAMP collaborative study group. CHromosomes And MorPhology.

Int J Cancer. 67: 632-635Barretina J. Taylor B.S. Banerji S. et al.

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.

Nat Genet. 42: 715-721Dalal K.M. Kattan M.W. Antonescu C.R. et al.

Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.

Ann Surg. 244: 381-391Taguchi S. Kume H. Fukuhara H. et al.

Symptoms at diagnosis as independent prognostic factors in retroperitoneal liposarcoma.

Mol Clin Oncol. 4: 255-260

Diagnosis and management of retroperitoneal soft-tissue sarcoma.

Ann Surg. 214: 2-10Swallow C.J. Strauss D.C. Bonvalot S. et al.

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group.

Ann Surg Oncol. 28: 7873-7888Mv Mehren Kane J.M. Bui M.M. et al.

NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021: Featured Updates to the NCCN Guidelines.

J Natl Compr Cancer Netw. 18: 1604-1612Gronchi A. Miah A.B. Dei Tos A.P. et al.GENTURIS

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 32: 1348-1365Setsu N. Miyake M. Wakai S. et al.

Primary Retroperitoneal Myxoid Liposarcomas.

Am J Surg Pathol. 40: 1286-1290Moreau L.-C. Turcotte R. Ferguson P. et al.

Myxoid∖round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases.

Ann Surg Oncol. 19: 1081-1088

Imaging in retroperitoneal soft tissue sarcoma.

J Surg Oncol. 117: 25-32Messiou C. Moskovic E. Vanel D. et al.

Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm.

Eur J Surg Oncol Jul. 43: 1191-1198Fairweather M. Wang J. Jo V.Y. et al.

Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection.

Ann Surg Oncol. 25: 98-106Craig W.D. Fanburg-Smith J.C. Henry L.R. et al.

Fat-containing lesions of the retroperitoneum: radiologic-pathologic correlation.

Radiographics. 29: 261-290Subramaniam S. Callahan J. Bressel M. et al.

The role of 18F-FDG PET/CT in retroperitoneal sarcomas—A multicenter retrospective study.

J Surg Oncol. 123: 1081-1087Rhu J. Hyun S.H. Lee K.-H. et al.

Maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma.

Scientific Rep. 9: 6605Hain S.F. O'Doherty M.J. Bingham J. et al.

Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours?.

Nucl Med Commun. 24: 1139-1143Young R. Snow H. Hendry S. et al.

Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single-centre study.

ANZ J Surg. 90: 497-502Rakheja R. Makis W. Skamene S. et al.

Correlating Metabolic Activity on 18 F-FDG PET/CT With Histopathologic Characteristics of Osseous and Soft-Tissue Sarcomas: A Retrospective Review of 136 Patients.

Am J Roentgenol. 198: 1409-1416Parkes A. Urquiola E. Bhosale P. et al.

PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma.

Sarcoma. 2020: 8363986

To Biopsy, or Not to Biopsy: Is There Really a Question?.

Ann Surg Oncol. 26: 4182-4184Strauss D.C. Qureshi Y.A. Hayes A.J. et al.

The role of core needle biopsy in the diagnosis of suspected soft tissue tumours.

J Surg Oncol. 102: 523-529van Houdt W.J. Raut C.P. Bonvalot S. et al.

New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration.

Curr Opin Oncol. 31: 310-316Berger-Richardson D. Burtenshaw S.M. Ibrahim A.M. et al.

Early and Late Complications of Percutaneous Core Needle Biopsy of Retroperitoneal Tumors at Two Tertiary Sarcoma Centers.

Ann Surg Oncol. 26: 4692-4698Van Houdt W.J. Schrijver A.M. Cohen-Hallaleh R.B. et al.

Needle tract seeding following core biopsies in retroperitoneal sarcoma.

Eur J Surg Oncol. 43: 1740-1745Weaver J. Downs-Kelly E. Goldblum J.R. et al.

Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms.

Mod Pathol. 21: 943-949Baranov E. Black M.A. Fletcher C.D.M. et al.

Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas.

Mod Pathol. 34: 1367-1372Brennan M.F. Antonescu C.R. Moraco N. et al.

Lessons learned from the study of 10,000 patients with soft tissue sarcoma.

Ann Surg. 260: 416-421Bonvalot S. Raut C.P. Pollock R.E. et al.

Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG.

Ann Surg Oncol. 19: 2981-2991Singer S. Antonescu C.R. Riedel E. et al.

Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.

Ann Surg. 238: 358-370Bonvalot S. Rivoire M. Castaing M. et al.

Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control.

J Clin Oncol. 27: 31-37Gronchi A. Lo Vullo S. Fiore M. et al.

Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients.

J Clin Oncol. 27: 24-30Gronchi A. Miceli R. Colombo C. et al.

Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas.

Ann Oncol. 23: 1067-1073Bonvalot S. Miceli R. Berselli M. et al.

Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control.

Ann Surg Oncol. 17: 1507-1514MacNeill A.J. Gronchi A. Miceli R. et al.

Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.

Ann Surg. 267: 959-964

Surgery in retroperitoneal soft tissue sarcoma: a call for a consensus between Europe and North America.

Ann Surg Oncol. 18: 2107-2110Mussi C. Colombo P. Bertuzzi A. et al.

Retroperitoneal sarcoma: is it time to change the surgical policy?.

Ann Surg Oncol. 18: 2136-2142Ikoma N. Roland C.L. Torres K.E. et al.

Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center.

J Surg Oncol. 117: 1188-1194Strauss D.C. Renne S.L. Gronchi A.

Adjacent, Adherent, Invaded: A Spectrum of Biologic Aggressiveness Rather Than a Rationale for Selecting Organ Resection in Surgery of Primary Retroperitoneal Sarcomas.

Ann Surg Oncol. 25: 13-16Keung E.Z. Chiang Y.J. Cormier J.N. et al.

Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.

Cancer. 124: 4495-4503Villano A.M. Zeymo A. Chan K.S. et al.

Identifying the Minimum Volume Threshold for Retroperitoneal Soft Tissue Sarcoma Resection: Merging National Data with Consensus Expert Opinion.

J Am Coll Surg. 230: 151-160 e2Albertsmeier M. Rauch A. Roeder F. et al.

External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis.

Ann Surg Oncol. 25: 754-767Diamantis A. Baloyiannis I. Magouliotis D.E. et al.

Perioperative radiotherapy versus surgery alone for retroperitoneal sarcomas: a systematic review and meta-analysis.

Radiol Oncol. 54: 14-21Gronchi A. Strauss D.C. Miceli R. et al.

Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.

Ann Surg. 263: 1002-1009Haas R.L.M. Bonvalot S. Miceli R. et al.

Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.

Cancer. 125: 1290-1300Bates J.E. Dhakal S. Mazloom A. et al.

The Benefit of Adjuvant Radiotherapy in High-grade Nonmetastatic Retroperitoneal Soft Tissue Sarcoma: A SEER Analysis.

Am J Clin Oncol. 41: 274-279Baldini E.H. Wang D. Haas R.L. et al.

Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel.

Int J Radiat Oncol Biol Phys. 92: 602-612Pawlik T.M. Ahuja N. Herman J.M.

The role of radiation in retroperitoneal sarcomas: a surgical perspective.

Curr Opin Oncol. 19: 359-366Jones J.J. Catton C.N. O'Sullivan B. et al.

Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma.

Ann Surg Oncol. 9: 346-354Krempien R. Roeder F. Oertel S. et al.

Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma.

Int J Radiat Oncol Biol Phys. 65: 773-779Bonvalot S. Gronchi A. Le Péchoux C. et al.

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.

Lancet Oncol. 21: 1366-1377

Callegaro D, Gronchi A, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 trial (STRASS) vs off-trial (STREXIT) results. Annals of Surgery 2022;in press.

Almond L.M. Gronchi A. Strauss D. et al.

Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma.

Eur J Surg Oncol. 44: 571-579Livingston J.A. Bugano D. Barbo A. et al.

Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard.

Scientific Rep. 7Jones R.L. Fisher C. Al-Muderis O. et al.

Differential sensitivity of liposarcoma subtypes to chemotherapy.

Eur J Cancer. 41: 2853-2860Constantinidou A. Jones R.L.

Systemic therapy in retroperitoneal sarcoma management.

J Surg Oncol. 117: 87-92Tseng W.W. Barretta F. Conti L. et al.

Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.

Cancer. 127: 729-738

Surgery With Our Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma.

Gronchi A. Collini P. Miceli R. et al.

Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma.

Am J Surg Pathol. 39: 383-393Tan M.C. Brennan M.F. Kuk D. et al.

Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.

Ann Surg. 263: 593-600Toulmonde M. Bonvalot S. Meeus P. et al.

Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.

Ann Oncol. 25: 735-742Stoeckle E. Coindre J.M. Bonvalot S. et al.

Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group.

Cancer. 92: 359-368Anaya D.A. Lahat G. Liu J. et al.

Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making.

Ann Surg. 249: 137-142Anaya D.A. Lev D.C. Pollock R.E.

The role of surgical margin status in retroperitoneal sarcoma.

J Surg Oncol. 98: 607-610Keung E.Z. Hornick J.L. Bertagnolli M.M. et al.

Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.

J Am Coll Surg. 218: 206-217Kattan M.W. Leung D.H. Brennan M.F.

Postoperative nomogram for 12-year sarcoma-specific death.

J Clin Oncol. 20: 791-796Anaya D.A. Lahat G. Wang X. et al.

Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent.

Ann Oncol. 21: 397-402Ardoino I. Miceli R. Berselli M. et al.

Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma.

Cancer. 116: 2429-2436Gronchi A. Miceli R. Shurell E. et al.

Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.

J Clin Oncol. 31: 1649-1655Stojadinovic A. Yeh A. Brennan M.F.

Completely resected recurrent soft tissue sarcoma: primary anatomic site governs outcomes.

J Am Coll Surg. 194: 436-447MacNeill A.J. Miceli R. Strauss D.C. et al.

Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.

Cancer. 123: 1971-1978van Houdt W.J. Fiore M. Barretta F. et al.

Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG.

Cancer. 126: 4917-4925Park J.O. Qin L.X. Prete F.P. et al.

Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.

Ann Surg. 250: 977-982Hamilton T.D. Cannell A.J. Kim M. et al.

Results of Resection for Recurrent or Residual Retroperitoneal Sarcoma After Failed Primary Treatment.

Ann Surg Oncol. 24: 211-218Trans-Atlantic R.P.S.W.G.

Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group.

Ann Surg Oncol. 23: 3531-3540Glasbey J.C. Bundred J. Tyler R. et al.

The impact of postoperative radiological surveillance intensity on disease free and overall survival from primary retroperitoneal, abdominal and pelvic soft-tissue sarcoma.

Eur J Surg Oncol. 47: 1771-1777Raut C.P. Callegaro D. Miceli R. et al.

Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.

Clin Cancer Res. 25: 2664-2671Casali P.G. Abecassis N. Aro H.T. et al.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 29: iv51-iv67Yahya Zaidi M. Cardona K.

Post-operative surveillance in soft tissue sarcoma: using tumor-specific recurrence patterns to direct approach.

Chin Clin Oncol. 7: 45Cipriano C.A. Jang E. Tyler W.

Sarcoma Surveillance: A Review of Current Evidence and Guidelines.

J Am Acad Orthop Surg. 28: 145-156Gerrand C.H. Billingham L.J. Woll P.J. et al.

Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom.

Sarcoma. : 34128Richardson K. Potter M. Damron T.A.

Image intensive soft tissue sarcoma surveillance uncovers pathology earlier than patient complaints but with frequent initially indeterminate lesions.

J Surg Oncol. 113: 818-822Goel A. Christy M.E. Virgo K.S. et al.

Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma.

Int J Oncol. 25: 429-435Fiore M. Brunelli C. Miceli R. et al.

A Prospective Observational Study of Multivisceral Resection for Retroperitoneal Sarcoma: Clinical and Patient-Reported Outcomes 1 Year After Surgery.

Ann Surg Oncol. 28: 3904-3916Bauml J.M. Troxel A. Epperson C.N. et al.

Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety.

Lung Cancer. 100: 110-113Tyldesley-Marshall N. Greenfield S. Neilson S.J. et al.

The role of Magnetic Resonance Images (MRIs) in coping for patients with brain tumours and their parents: a qualitative study.

BMC cancer. 21: 1013Perhavec A. Provenzano S. Baia M. et al.

Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution.

Ann Surg Oncol. 28: 1151-1157Pasquali S. Palassini E. Stacchiotti S. et al.

Neoadjuvant treatment: a novel standard?.

Curr Opin Oncol. 29: 253-259Callegaro D. Raut C.P. Swallow C.J. et al.

Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group Program.

Curr Opin Oncol. 33: 301-308